ESR1 and breast cancer: Besides, combination of genistein and centchroman (a selective estrogen receptor modulator) showed significantly higher cytotoxicity in human breast cancer cell lines compared to each drug used alone, and the nontumorigenic human mammary epithelial cell remained unaffected [271].